Research Topics
Species | Ralph DefronzoSummaryAffiliation: University of Texas Health Science Center Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Efficacy and Safety of SGLT2 Inhibitors in the Treatment of Type 2 Diabetes MellitusMuhammad A Abdul-Ghani
Division of Diabetes, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX, 78229, USA
Curr Diab Rep 12:230-8. 2012..In this review, we summarize the available data concerning the mechanism of action, efficacy, and safety of this novel antidiabetic class of therapeutic agents...
Efficacy and Tolerability of the DPP-4 Inhibitor Alogliptin Combined with Pioglitazone, in Metformin-Treated Patients with Type 2 DiabetesR A DeFronzo
University of Texas Health Sciences Center, Diabetes Division, 7703 Floyd Curl Drive, San Antonio, Texas 78229
J Clin Endocrinol Metab 97:1615-22. 2012..The decreases in HbA(1c) with A12.5+P and A25+P were similar. All treatments were well tolerated...
Visceral fat dominant distribution in male type 2 diabetic patients is closely related to hepatic insulin resistance, irrespective of body typeYoshinori Miyazaki
Department of Medicine, Diabetes Division, University of Texas Health Science Center, San Antonio, TX, USA
Cardiovasc Diabetol 8:44. 2009..This ratio defines the predominancy of visceral or subcutaneous abdominal adiposity, independent of the body type of each individual...
Predictive models of insulin resistance derived from simple morphometric and biochemical indices related to obesity and the metabolic syndrome in baboonsAlberto O Chavez
Department of Medicine, Diabetes Division, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
Cardiovasc Diabetol 8:22. 2009..e. percent body fat by DXA and HbA1c). However, a simple method to screen and identify obese insulin resistant baboons for inclusion in interventional studies is not available...
Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patientsYoshinori Miyazaki
University of Texas Health Science Center, Diabetes Division, Room 3 380S, 7703 Floyd Curl Drive, San Antonio, Texas 78229 3900, USA
J Clin Endocrinol Metab 89:4312-9. 2004....
Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucoseMuhammad A Abdul-Ghani
Division of Diabetes, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr, San Antonio, TX 78229, USA
Diabetes Care 29:1130-9. 2006..The distinct metabolic features present in subjects with IFG and IGT may require different therapeutic interventions to prevent their progression to type 2 diabetes...
The efficacy and safety of saxagliptin when added to metformin therapy in patients with inadequately controlled type 2 diabetes with metformin aloneRalph A DeFronzo
University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA
Diabetes Care 32:1649-55. 2009..This 24-week trial assessed the efficacy and safety of saxagliptin as add-on therapy in patients with type 2 diabetes with inadequate glycemic control with metformin alone...
Actos Now for the prevention of diabetes (ACT NOW) studyRalph A DeFronzo
Texas Diabetes Institute and University of Texas Health Science Center, San Antonio, TX, USA
BMC Endocr Disord 9:17. 2009..TRIAL REGISTRATION: clinical trials.gov identifier: NCT00220961...
Relationship of baseline HbA1c and efficacy of current glucose-lowering therapies: a meta-analysis of randomized clinical trialsR A DeFronzo
Department of Medicine, Division of Diabetes, University of Texas Health Science Center, San Antonio, TX 78229 3900, USA
Diabet Med 27:309-17. 2010..The objective of this study is to quantify the relationship between baseline HbA(1c) and reduction of HbA(1c) in clinical trials...
Role of sodium-glucose cotransporter 2 (SGLT 2) inhibitors in the treatment of type 2 diabetesMuhammad A Abdul-Ghani
Diabetes Division, University of Texas Health Science Center, San Antonio, USA
Endocr Rev 32:515-31. 2011..In this review, we will summarize the available data concerning the mechanism of action, efficacy, and safety of this novel antidiabetic therapeutic approach...
Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009R A DeFronzo
Diabetes Division, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive MSC 7886, San Antonio, TX, 78229, USA
Diabetologia 53:1270-87. 2010..Insulin resistance and lipotoxicity represent the missing links (beyond the classical cardiovascular risk factors) that help explain the accelerated rate of CVD in type 2 diabetic patients...
Current issues in the treatment of type 2 diabetes. Overview of newer agents: where treatment is goingRalph A DeFronzo
Diabetes Division, University of Texas Health Science Center, San Antonio, Texas 78249 1644, USA
Am J Med 123:S38-48. 2010..Optimal management of type 2 diabetes should include early initiation of therapy using multiple drugs, with different mechanisms of action, in combination...
Determinants of glucose tolerance in impaired glucose tolerance at baseline in the Actos Now for Prevention of Diabetes (ACT NOW) studyR A DeFronzo
Diabetes Division, University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA
Diabetologia 53:435-45. 2010..The aim of the study was to examine the determinants of oral glucose tolerance in 602 persons with impaired glucose tolerance (IGT) who participated in the Actos Now for Prevention of Diabetes (ACT NOW) study...
Association of high body mass index with low age of disease onset among Arab women with type 2 diabetes in a primary care clinicMuhammad A Abdul-Ghani
Department of Diabetes, Lin Medical Center, Ibelin Clinic, Clalit Health Services, Haifa, Israel
Isr Med Assoc J 7:360-3. 2005..Type 2 diabetes is usually associated with obesity, and both conditions are frequently detected in the Arab population in Israel. Recent studies have demonstrated that diabetes can be prevented by a change in lifestyle...
Efficacy of inhaled insulin in patients with type 2 diabetes not controlled with diet and exercise: a 12-week, randomized, comparative trialRalph A DeFronzo
University of Texas Health Science Center, Diabetes Division, 7703 Floyd Curl Dr, San Antonio, TX 78284, USA
Diabetes Care 28:1922-8. 2005..This study investigates whether inhaled insulin (INH; Exubera) can achieve target glycemic control in patients failing on diet and exercise...
Type 2 diabetes can be prevented with early pharmacological interventionRalph A DeFronzo
Diabetes Division, University of Texas Health Science Center, San Antonio, Texas, USA
Diabetes Care 34:S202-9. 2011....
Preservation of ?-cell function: the key to diabetes preventionRalph A DeFronzo
University of Texas Health Science Center, San Antonio, Texas 78229 3900, USA
J Clin Endocrinol Metab 96:2354-66. 2011..Therefore, preservation of the remaining 20-30% of ?-cell function is critical to prevent future development of T2DM...
Effects of exenatide plus rosiglitazone on beta-cell function and insulin sensitivity in subjects with type 2 diabetes on metforminRalph A DeFronzo
Division of Diabetes, Department of Medicine, University of Texas Health Science Center, San Antonio, Texas, USA
Diabetes Care 33:951-7. 2010..Study the effects of exenatide (EXE) plus rosiglitazone (ROSI) on beta-cell function and insulin sensitivity using hyperglycemic and euglycemic insulin clamp techniques in participants with type 2 diabetes on metformin...
The role of the kidneys in glucose homeostasis: a new path towards normalizing glycaemiaR A DeFronzo
Diabetes Division, Department of Medicine, University of Texas Health Science Center, San Antonio, TX 78229, USA
Diabetes Obes Metab 14:5-14. 2012..Although the long-term efficacy and safety of SGLT2 inhibitors remain under study, the class represents a novel therapeutic approach with potential for the treatment of both type 2 and 1 diabetes...
Adipocytes in subjects with impaired fasting glucose and impaired glucose tolerance are resistant to the anti-lipolytic effect of insulinMuhammad A Abdul-Ghani
Diabetes Division, University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA
Acta Diabetol 45:147-50. 2008....
Pioglitazone for diabetes prevention in impaired glucose toleranceRalph A DeFronzo
Texas Diabetes Institute and University of Texas Health Science Center, San Antonio, TX 78229, USA
N Engl J Med 364:1104-15. 2011..Impaired glucose tolerance is associated with increased rates of cardiovascular disease and conversion to type 2 diabetes mellitus. Interventions that may prevent or delay such occurrences are of great clinical importance...
Effects of exenatide versus sitagliptin on postprandial glucose, insulin and glucagon secretion, gastric emptying, and caloric intake: a randomized, cross-over studyRalph A DeFronzo
University of Texas Health Science Center, Department of Medicine, Diabetes Division MSC 7886, 7703 Floyd Curl Drive, San Antonio, TX 78229 3900, USA
Curr Med Res Opin 24:2943-52. 2008..This study evaluated the effects of exenatide, a GLP-1 receptor agonist, and sitagliptin, a DPP-4 inhibitor, on 2-h postprandial glucose (PPG), insulin and glucagon secretion, gastric emptying, and caloric intake in T2D patients...
Fasting hyperglycemia impairs glucose- but not insulin-mediated suppression of glucagon secretionMuhammad Abdul-Ghani
Diabetes Division, University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA
J Clin Endocrinol Metab 92:1778-84. 2007..Our aim was to assess the effect of chronic hyperglycemia on glucose- and insulin-mediated suppression of glucagon secretion by the alpha-cell...
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes and inadequate glycemic control: a randomized, double-blind, placebo-controlled studyRalph A DeFronzo
University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA
Diabetes Care 31:2315-7. 2008..To evaluate the dipeptidyl peptidase-4 (DPP-4) inhibitor alogliptin in drug-naïve patients with inadequately controlled type 2 diabetes...
What is the best predictor of future type 2 diabetes?Muhammad A Abdul-Ghani
Division of Diabetes, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229, USA
Diabetes Care 30:1544-8. 2007..We sought to assess insulin secretion/insulin resistance index in predicting the risk for future type 2 diabetes..
Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucoseRalph A DeFronzo
Diabetes Division, University of Texas Health Science Center, San Antonio, Texas 78229, USA
Am J Cardiol 108:3B-24B. 2011..The treatment of these CV risk factors should follow the same guidelines established for patients with type 2 diabetes, and should be aggressively followed to reduce future CV events...
Addition of pioglitazone and ramipril to intensive insulin therapy in type 2 diabetic patients improves vascular dysfunction by different mechanismsMarianella Fernandez
Texas Diabetes Institute, San Antonio, Texas, USA
Diabetes Care 31:121-7. 2008..We examined the relationship between glycemic control, vascular reactivity, and inflammation in type 2 diabetic subjects...
Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patientsMandeep Bajaj
Diabetes Division, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78284 7886, USA
J Clin Endocrinol Metab 89:200-6. 2004....
Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetesSangeeta R Kashyap
Diabetes Division, Department of Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229, USA
Am J Physiol Endocrinol Metab 287:E537-46. 2004....
Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucoseMuhammad A Abdul-Ghani
Diabetes Division, University of Texas Health Science Center, 7703 Floyd Curl Dr, MS 7886, San Antonio, 78229, USA
Diabetes Care 29:1613-8. 2006....
Reduction in hematocrit level after pioglitazone treatment is correlated with decreased plasma free testosterone level, not hemodilution, in women with polycystic ovary syndromeRachele Berria
Division of Diabetes, Department of Medicine Department of Obstetrics and Gynecology, The University of Texas Health Science Center at San Antonio, San Antonio, TX 78229-3900, USA
Clin Pharmacol Ther 80:105-14. 2006..Further studies are necessary to evaluate whether the same scenario is applicable to normoandrogenic women and individuals with type 2 diabetes mellitus...
Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetesMandeep Bajaj
Diabetes Division, Department of Medicine, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78284 7886, USA
Diabetes 52:1364-70. 2003..Improved splanchnic/peripheral glucose uptake and enhanced suppression of EGP contribute to the improvement in glycemic control in patients with type 2 diabetes...
Retinol-binding protein 4 is associated with impaired glucose tolerance but not with whole body or hepatic insulin resistance in Mexican AmericansAlberto O Chavez
Diabetes Division, South Texas Veterans Health Care System, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr, San Antonio, TX 78229, USA
Am J Physiol Endocrinol Metab 296:E758-64. 2009..Plasma RBP4 levels are elevated in T2DM and associated with impaired glucose tolerance, but not associated with obesity or insulin resistance or impaired insulin secretion in Mexican Americans...
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitisRenata Belfort
University of Texas Health Science Center at San Antonio, San Antonio, TX 78229-3900, USA
N Engl J Med 355:2297-307. 2006..Larger controlled trials of longer duration are warranted to assess the long-term clinical benefit of pioglitazone. (ClinicalTrials.gov number, NCT00227110 [ClinicalTrials.gov] .)...
Rosiglitazone improves downstream insulin receptor signaling in type 2 diabetic patientsYoshinori Miyazaki
University of Texas Health Science Center, San Antonio, Texas, USA
Diabetes 52:1943-50. 2003..In conclusion, in type 2 diabetic patients, rosiglitazone treatment enhances downstream insulin receptor signaling in muscle and decreases plasma FFA concentration while improving glycemic control...
Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetesAntonio Cervera
Division of Diabetes, Department of Medicine, University of Texas Health Science Center, San Antonio, TX, USA
Am J Physiol Endocrinol Metab 294:E846-52. 2008..CON). Acetaminophen((AUC)) was reduced by approximately 80% in EXE vs. CON (P < 0.01). We conclude that exenatide infusion attenuates postprandial hyperglycemia by decreasing EGP (by approximately 50%) and by slowing gastric emptying...
Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetesRalph A DeFronzo
Division of Diabetes, University of Texas Health Science Center, San Antonio, TX, USA
Diabetes Care 28:1092-100. 2005..CONCLUSIONS: Exenatide was generally well tolerated and reduced HbA(1c) with no weight gain and no increased incidence of hypoglycemia in patients with type 2 diabetes failing to achieve glycemic control with metformin...
Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistanceAlberto O Chavez
Division of Diabetes, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA
Diabetes Care 32:1542-6. 2009..FGF-21 may play a role in pathogenesis of hepatic and whole-body insulin resistance in type 2 diabetes...
Decreased non-insulin-dependent glucose clearance contributes to the rise in fasting plasma glucose in the nondiabetic rangeRucha Jani
Division of Diabetes, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229, USA
Diabetes Care 31:311-5. 2008..To assess the contribution of decreased glucose clearance to the rise in fasting plasma glucose (FPG) in the nondiabetic range...
Pioglitazone and alogliptin combination therapy in type 2 diabetes: a pathophysiologically sound treatmentCurtis Triplitt
Diabetes Division, Department of Medicine, University of Texas, Health Science Center at San Antonio, San Antonio, Texas 78229 3900, USA
Vasc Health Risk Manag 6:671-90. 2010..The alogliptin-pioglitazone combination represents a pathophysiologically sound treatment of T2DM...
NF-?B activity in muscle from obese and type 2 diabetic subjects under basal and exercise-stimulated conditionsPuntip Tantiwong
Texas Diabetes Institute, University of Texas Health Science Center at San Antonio, USA
Am J Physiol Endocrinol Metab 299:E794-801. 2010..Exercise-induced MCP-1 and IL-6 gene expression precedes increases in NF-?B activity, suggesting that other factors promote gene expression of these cytokines during exercise...
Comparison of glargine insulin versus rosiglitazone addition in poorly controlled type 2 diabetic patients on metformin plus sulfonylureaCurtis Triplitt
Diabetes Division, MSC 7886, University of Texas Health Science Center, San Antonio, TX 78229-3900, USA
Diabetes Care 29:2371-7. 2006..Glargine insulin reduced basal EGP by increasing plasma insulin levels, while rosiglitazone decreased basal hepatic glucose production by improving hepatic insulin sensitivity...
Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitusYoshinori Miyazaki
University of Texas Health Science Center and Texas Diabetes Institute, San Antonio, Texas 78229-3900, USA
Am J Physiol Endocrinol Metab 283:E1135-43. 2002..In male but not female T2DM, deep subcutaneous adipose tissue also is associated with peripheral and hepatic insulin resistance...
Physiological and molecular determinants of insulin action in the baboonAlberto O Chavez
Diabetes Division, Department of Medicine, The University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr, San Antonio, TX 78229, USA
Diabetes 57:899-908. 2008..To quantitate insulin sensitivity in lean and obese nondiabetic baboons and examine the underlying cellular/molecular mechanisms responsible for impaired insulin action to characterize a baboon model of insulin resistance...
Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patientsYoshinori Miyazaki
University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA
J Clin Endocrinol Metab 87:2784-91. 2002..These results demonstrate that a shift of fat distribution from visceral to sc adipose depots after pioglitazone treatment is associated with improvements in hepatic and peripheral tissue sensitivity to insulin...
Lipid infusion decreases the expression of nuclear encoded mitochondrial genes and increases the expression of extracellular matrix genes in human skeletal muscleDawn K Richardson
Division of Diabetes, Department of Medicine, The University of Texas Health Science Center, San Antonio, Texas 78229, USA
J Biol Chem 280:10290-7. 2005..These data suggest that an experimental increase in FFAs decreases the expression of PGC-1 and nuclear encoded mitochondrial genes and also increases the expression of extracellular matrix genes in a manner reminiscent of inflammation...
Effects of pioglitazone on intramyocellular fat metabolism in patients with type 2 diabetes mellitusMandeep Bajaj
Diabetes Division, Department of Medicine, University of Texas Health Science Center, San Antonio, Texas 77030, USA
J Clin Endocrinol Metab 95:1916-23. 2010..Objective: The aim was to study the effect of pioglitazone on intramyocellular fat metabolism...
Insulin resistance is associated with impaired nitric oxide synthase activity in skeletal muscle of type 2 diabetic subjectsSangeeta R Kashyap
The University of Texas Health Science Center at San Antonio, Diabetes Division, Texas 78229, USA
J Clin Endocrinol Metab 90:1100-5. 2005..These results suggest that impaired NOS activity may play an important role in the insulin resistance in type 2 diabetic individuals...
Sustained reduction in plasma free fatty acid concentration improves insulin action without altering plasma adipocytokine levels in subjects with strong family history of type 2 diabetesMandeep Bajaj
Diabetes Division, Department of Medicine, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, Texas 78284 7886, USA
J Clin Endocrinol Metab 89:4649-55. 2004....
A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetesSangeeta Kashyap
Diabetes Division, Department of Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, Texas 78284-3900, USA
Diabetes 52:2461-74. 2003....
A meta-analysis comparing the effect of thiazolidinediones on cardiovascular risk factorsElaine Chiquette
University of Texas Health Science Center, San Antonio, TX 78229, USA
Arch Intern Med 164:2097-104. 2004..Head-to-head comparative trials as well as longer-term cardiovascular outcome studies are needed to determine whether there are differences in efficacy between the 2 thiazolidinediones...
Elevated toll-like receptor 4 expression and signaling in muscle from insulin-resistant subjectsSara M Reyna
Diabetes Division, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA
Diabetes 57:2595-602. 2008..CONCLUSIONS- Abnormal TLR4 expression and signaling, possibly caused by elevated plasma FFA levels, may contribute to the pathogenesis of insulin resistance in humans...
Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjectsAmalia Gastaldelli
Division of Diabetes, Department of Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA
Gastroenterology 133:496-506. 2007..We examined the relationship between visceral/hepatic fat accumulation and hepatic IR/accelerated gluconeogenesis (GNG)...
Effect of short-term free Fatty acids elevation on mitochondrial function in skeletal muscle of healthy individualsAlberto O Chavez
Division of Diabetes, Department of Medicine, University of Texas Health Science Center at San Antonio, Texas 78229, USA
J Clin Endocrinol Metab 95:422-9. 2010..Mitochondrial dysfunction has been proposed as an underlying mechanism in the pathogenesis of insulin resistance and type 2 diabetes mellitus...
Dose-response effect of pioglitazone on insulin sensitivity and insulin secretion in type 2 diabetesYoshinori Miyazaki
University of Texas Health Science Center and Texas Diabetes Institute, San Antonio, Texas 78229-3900, USA
Diabetes Care 25:517-23. 2002..44), and whole-body ISI (r=0.36) were observed. CONCLUSIONS: Pioglitazone improves glycemic control through the dose-dependent enhancement of beta-cell function and improved whole-body and hepatic insulin sensitivity...
Dose-response effect of a single administration of oral hexyl-insulin monoconjugate 2 in healthy nondiabetic subjectsEstela Wajcberg
University of Texas Health Science Center, Diabetes Division, 7703 Floyd Curl Dr, San Antonio, TX 78229-3900, USA
Diabetes Care 27:2868-73. 2004..Oral HIM2 may provide an effective and reproducible means of controlling postprandial plasma glucose excursions in diabetic patients...
Effect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjectsThongchai Pratipanawatr
Diabetes Division, Department of Medicine, University of Texas Health Science Center, San Antonio, Texas 78229-3900, USA
Am J Physiol Endocrinol Metab 282:E1360-8. 2002..However, suppression of EGP by IGF-I is not impaired in diabetic individuals, indicating normal hepatic sensitivity to IGF-I...
Free fatty acids reduce splanchnic and peripheral glucose uptake in patients with type 2 diabetesMandeep Bajaj
Diabetes Division, Department of Medicine, University of Texas Health Science Center at San Antonio, 78284, USA
Diabetes 51:3043-8. 2002..37 +/- 2%, P < 0.01). In conclusion, an elevation in plasma FFA concentration impairs both peripheral and SGU in patients with type 2 diabetes...
Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty Acyl-CoAs and insulin action in type 2 diabetic patientsMandeep Bajaj
Diabetes Division, Department of Medicine, University of Texas Health Science Center, San Antonio, Texas, USA
Diabetes 54:3148-53. 2005....
Thiazolidinediones improve beta-cell function in type 2 diabetic patientsAmalia Gastaldelli
Diabetes Division, Department of Medicine, University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA
Am J Physiol Endocrinol Metab 292:E871-83. 2007..In T2DM patients, TZD treatment leads to improved beta-cell function, which correlates strongly with improved glycemic control...
Efficacy and safety of Technosphere inhaled insulin compared with Technosphere powder placebo in insulin-naive type 2 diabetes suboptimally controlled with oral agentsJulio Rosenstock
Dallas Diabetes and Endocrine Center at Medical City, Dallas, Texas, USA
Diabetes Care 31:2177-82. 2008....
Muscle glucose transport and phosphorylation in type 2 diabetic, obese nondiabetic, and genetically predisposed individualsMerri Pendergrass
Univ of Texas Health Science Center, Diabetes Division, 703 Floyd Curl Dr, San Antonio, TX 78229, USA
Am J Physiol Endocrinol Metab 292:E92-100. 2007....
Tumor necrosis factor alpha and insulin resistance in obese type 2 diabetic patientsY Miyazaki
University of Texas Health Science Center and Texas Diabetes Institute, San Antonio, Texas 78229, USA
Int J Obes Relat Metab Disord 27:88-94. 2003....
Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology StudyMuhammad A Abdul-Ghani
Diabetes Division, University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA
Diabetes 55:1430-5. 2006..Differences in insulin sensitivity and insulin secretion may predict different rates of progression to type 2 diabetes and varying susceptibility to cardiovascular disease...
Muscle and liver insulin resistance indexes derived from the oral glucose tolerance testMuhammad A Abdul Ghani
Division of Diabetes, University of Texas Health Science Center, San Antonio, TX 78229, USA
Diabetes Care 30:89-94. 2007..To derive indexes for muscle and hepatic insulin sensitivity from the measurement of plasma glucose and insulin concentrations during an oral glucose tolerance test (OGTT)...
Free fatty acid-induced peripheral insulin resistance augments splanchnic glucose uptake in healthy humansMandeep Bajaj
Diabetes Division, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78284, USA
Am J Physiol Endocrinol Metab 283:E346-52. 2002..Sal infusion study (30 +/- 2 vs. 20 +/- 2%, P < 0.005). In conclusion, an elevation in plasma FFA concentration impairs whole body glucose R(d) and insulin-mediated suppression of EGP in healthy subjects but augments SGU...
Relationship between vascular reactivity and lipids in Mexican-Americans with type 2 diabetes treated with pioglitazoneEstela Wajcberg
Division of Diabetes, Department of Medicine, University of Texas Health Science Center at San Antonio, Mail Code 7886, 7703 Floyd Curl Drive, San Antonio, Texas 78229 3900, USA
J Clin Endocrinol Metab 92:1256-62. 2007..Vascular dysfunction and insulin resistance precede atherosclerosis in type 2 diabetes (T2DM). Better knowledge of the interaction between these is of considerable clinical interest...
Genome-wide linkage scan for genes influencing plasma triglyceride levels in the Veterans Administration Genetic Epidemiology StudyDawn K Coletta
Division of Diabetes, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA
Diabetes 58:279-84. 2009..The goal of our study was to perform a genome-wide linkage scan to identify genetic regions that influence variation in plasma triglyceride levels in families that are enriched with individuals with type 2 diabetes...
LKB1-AMPK signaling in muscle from obese insulin-resistant Zucker rats and effects of trainingApiradee Sriwijitkamol
Diabetes Division, University of Texas Health Science Center at San Antonio, TX, USA
Am J Physiol Endocrinol Metab 290:E925-32. 2006..54, P = 0.02), and PGC-1alpha protein content (r = 0.81, P < 0.001). In summary, obese insulin-resistant rodents have abnormalities in the LKB1-AMPK-PGC-1 pathway in muscle, and these abnormalities can be restored by training...
Reduced skeletal muscle inhibitor of kappaB beta content is associated with insulin resistance in subjects with type 2 diabetes: reversal by exercise trainingApiradee Sriwijitkamol
Diabetes Division, University of Texas Health Science Center at San Antonio, USA
Diabetes 55:760-7. 2006..In summary, subjects with type 2 diabetes have reduced IkappaB protein abundance in muscle, suggesting excessive activity of the IkappaB/NFkappaB pathway. Moreover, this abnormality is reversed by exercise training...
Pancreatic islet amyloidosis, beta-cell apoptosis, and alpha-cell proliferation are determinants of islet remodeling in type-2 diabetic baboonsRodolfo Guardado-Mendoza
Department of Medicine Diabetes Division, University of Texas Health Science Center, San Antonio, TX 78229, USA
Proc Natl Acad Sci U S A 106:13992-7. 2009..519, P < 0.0001), and different FPG levels were sensitive and specific to predict IA severity. Finally, a predictive model for islet amyloid severity was generated with age and FPG as required variables...
beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysisEle Ferrannini
Diabetes Division, Department of Internal Medicine, University of Texas Health Science Center, San Antonio 78229 3900, USA
J Clin Endocrinol Metab 90:493-500. 2005....
Pathogenesis of type 2 diabetes mellitusRalph A DeFronzo
Diabetes Division, University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA
Med Clin North Am 88:787-835, ix. 2004....
Glucagon dose-response curve for hepatic glucose production and glucose disposal in type 2 diabetic patients and normal individualsMasafumi Matsuda
Diabetes Division, Department of Medicine, University of Texas Health Science Center at San Antonio, 78229, USA
Metabolism 51:1111-9. 2002..The late (120 to 240 minutes) stimulation of hepatic glucose output (which primarily reflects gluconeogenesis) by glucagon tends to be increased, especially at supraphysiologic plasma glucagon concentrations...
AMP-activated protein kinase: Role in metabolism and therapeutic implicationsGreg Schimmack
Texas Diabetes Institute, University of Texas Health Science Center at San Antonio, San Antonio, TX 78207, USA
Diabetes Obes Metab 8:591-602. 2006....
Peripheral disruption of the Grb10 gene enhances insulin signaling and sensitivity in vivoLixin Wang
Department of Pharmacology, UTHSCSA, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA
Mol Cell Biol 27:6497-505. 2007..Taken together, our results provide strong evidence that Grb10 is a negative regulator of insulin signaling and action in vivo...
Effect of acute physiological hyperinsulinemia on gene expression in human skeletal muscle in vivoDawn K Coletta
Division of Diabetes, Department of Medicine, University of Texas Health Science Centre, San Antonio, TX, USA
Am J Physiol Endocrinol Metab 294:E910-7. 2008..The results of the present study demonstrate that insulin acutely regulates the levels of mRNAs involved in inflammation and transcription and identifies several candidate genes, including HES1 and BHLHB2, for further investigation...
Identification of individuals with insulin resistance using routine clinical measurementsSteven E Stern
School of Finance and Applied Statistics, Australian National University, Canberra, Australia
Diabetes 54:333-9. 2005..1%), sensitivity (81.3%), and specificity (76.3%). Thus, insulin-resistant individuals can be identified using simple decision rules that can be tailored to specific needs...
One-hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetesMuhammad A Abdul-Ghani
Divisions of Diabetes and Epidemiology, University of Texas Health Science Center at San Antonio, Texas, USA
Diabetes Care 31:1650-5. 2008..To assess the efficacy of 1-h plasma glucose concentration and the metabolic syndrome in predicting future risk of type 2 diabetes...
The relationship between fasting hyperglycemia and insulin secretion in subjects with normal or impaired glucose toleranceMuhammad A Abdul-Ghani
Diabetes Division, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA
Am J Physiol Endocrinol Metab 295:E401-6. 2008....
The dipeptidyl peptidase IV inhibitor vildagliptin suppresses endogenous glucose production and enhances islet function after single-dose administration in type 2 diabetic patientsBogdan Balas
Diabetes Division, Department of Medicine, University of Texas Health Science Center at San Antonio, 7703 Floyd Drive, MC 7886, San Antonio, Texas 78229, USA
J Clin Endocrinol Metab 92:1249-55. 2007..However, little is known about the mechanism(s) by which vildagliptin promotes reduction in plasma glucose concentration...
A quantitative trait locus (QTL) on chromosome 6q influences birth weight in two independent family studiesRector Arya
Division of Clinical Epidemiology, University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, 78229 3900, USA
Hum Mol Genet 15:1569-79. 2006..3 to 2.7. Thus, we have found strong evidence for a major gene on chromosome 6q that influences variation in birth weight in both Mexican- and European-Americans...
The ontogeny of insulin signaling in the preterm baboon modelCynthia L Blanco
Department of Pediatrics, Diabetes Division, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229, USA
Endocrinology 151:1990-7. 2010..Reduced muscle content of key glucose transport-regulating proteins (GLUT1, GLUT4, AS160) could play a role in the pathogenesis of neonatal hyperglycemia and reduced insulin-stimulated glucose disposal...
Minimal contribution of fasting hyperglycemia to the incidence of type 2 diabetes in subjects with normal 2-h plasma glucoseMuhammad A Abdul-Ghani
Division of Diabetes, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA
Diabetes Care 33:557-61. 2010..After controlling for 1-h plasma glucose concentration, the increase in FPG concentration is not associated with an increase in the incidence of type 2 diabetes...
Pathogenesis of insulin resistance in skeletal muscleMuhammad A Abdul-Ghani
Division of Diabetes, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr, San Antonio, TX 78229, USA
J Biomed Biotechnol 2010:476279. 2010..In this review, we summarize the cellular and molecular defects that contribute to the development of insulin resistance in skeletal muscle...
Fasting versus postload plasma glucose concentration and the risk for future type 2 diabetes: results from the Botnia StudyMuhammad A Abdul-Ghani
Division of Diabetes, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA
Diabetes Care 32:281-6. 2009....
Pathophysiology of prediabetesMuhammad A Abdul-Ghani
Diabetes Division, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA
Curr Diab Rep 9:193-9. 2009..In this article, we summarize the metabolic abnormalities that characterize each state and the contribution of these metabolic abnormalities to the increased risk of diabetes and cardiovascular disease...
The shape of plasma glucose concentration curve during OGTT predicts future risk of type 2 diabetesMuhammad A Abdul-Ghani
Division of Diabetes, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA
Diabetes Metab Res Rev 26:280-6. 2010..The aim of the study is to assess the relationship between the shape of plasma glucose concentration during the OGTT and future risk for T2DM...
Association of neuropeptide Y receptor Y5 polymorphisms with dyslipidemia in Mexican AmericansDawn K Coletta
Division of Diabetes MC 7886, Department of Medicine, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229 3900, USA
Obesity (Silver Spring) 15:809-15. 2007..98). These preliminary results provide evidence for association of SNPs in the NPY5R gene with dyslipidemia (elevated triglyceride concentrations and reduced high-density lipoprotein levels) in our Mexican American population...
Deleterious action of FA metabolites on ATP synthesis: possible link between lipotoxicity, mitochondrial dysfunction, and insulin resistanceMuhammad A Abdul-Ghani
Division of Diabetes, Univ of Texas Health Science Center, San Antonio, TX 78229, USA
Am J Physiol Endocrinol Metab 295:E678-85. 2008..These acquired mitochondrial defects, caused by a physiological increase in the concentration of FFA metabolites, provide a mechanistic link between lipotoxicity, mitochondrial dysfunction, and muscle insulin resistance...
Association of genetic variation in ENPP1 with obesity-related phenotypesChristopher P Jenkinson
Division of Diabetes, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA
Obesity (Silver Spring) 16:1708-13. 2008..However, these results indicate that ENPP1 is a genetic determinant of these traits in this population, and are consistent with multiple positive association findings in independent studies in diverse human populations...
Mitochondrial dysfunction, insulin resistance, and type 2 diabetes mellitusMuhammad A Abdul-Ghani
Diabetes Division, University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA
Curr Diab Rep 8:173-8. 2008..This review summarizes evidence that implicates a defect in mitochondrial oxidative phosphorylation and its relationship to insulin resistance in common metabolic diseases characterized by impaired insulin action...
Is insulin resistance atherogenic? Possible mechanismsRalph A DeFronzo
Diabetes Division, The University of Texas Health Science Center, San Antonio, TX, USA
Atheroscler Suppl 7:11-5. 2006
Comprehensive assessment of postischemic vascular reactivity in Hispanic children and adults with and without diabetes mellitusEstela Wajcberg
University of Texas Health Science Center and Texas Diabetes Institute, San Antonio, TX 78229 3900, USA
Pediatr Diabetes 7:329-35. 2006....
Effect of exenatide on splanchnic and peripheral glucose metabolism in type 2 diabetic subjectsE Cersosimo
Division of Diabetes, Department of Medicine, University of Texas Health Science Center, San Antonio, Texas 78229, USA
J Clin Endocrinol Metab 96:1763-70. 2011..Our objective was to examine the mechanisms via which exenatide attenuates postprandial hyperglycemia in type 2 diabetes mellitus (T2DM)...
Metabolic effects of visceral fat accumulation in type 2 diabetesAmalia Gastaldelli
Metabolism Unit, Department of Internal Medicine, University of Pisa, Via Savi, I-56100 Pisa, Italy
J Clin Endocrinol Metab 87:5098-103. 2002..05). We conclude that in patients with established type 2 diabetes, VF accumulation has a significant negative impact on glycemic control through a decrease in peripheral insulin sensitivity and an enhancement of gluconeogenesis...
Impaired fasting glucose and impaired glucose tolerance: implications for careDavid M Nathan
Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA
Diabetes Care 30:753-9. 2007
Influence of ethnicity and familial diabetes on glucose tolerance and insulin action: a physiological analysisEle Ferrannini
Metabolism Unit, National Research Council Institute of Clinical Physiology and Department of Internal Medicine, University of Pisa School of Medicine, Pisa 56100, Italy
J Clin Endocrinol Metab 88:3251-7. 2003..We conclude that the primary physiological target of the propensity to diabetes of Mexican-Americans is insulin resistance of glucose uptake...
Effect of acute exercise on AMPK signaling in skeletal muscle of subjects with type 2 diabetes: a time-course and dose-response studyApiradee Sriwijitkamol
Texas Diabetes Institute, and Diabetes Division, University of Texas Health Science Center at San Antonio, TX 78207, USA
Diabetes 56:836-48. 2007..Our findings suggest that obese type 2 diabetic subjects may need to exercise at higher intensity to stimulate the AMPK-AS160 axis to the same level as lean subjects...
Insulin reduces plasma arginase activity in type 2 diabetic patientsSangeeta R Kashyap
Department of Endocrinology, Diabetes and Metabolism, Cleveland Clinic, Cleveland, Ohio, USA
Diabetes Care 31:134-9. 2008..We sought to determine whether dysregulation of arginine metabolism is related to insulin resistance and underlies impaired nitric oxide (NO) generation in type 2 diabetic patients...
The effect of pioglitazone on the liver: role of adiponectinAmalia Gastaldelli
Stable Isotope Lab, Institute of Clinical Physiology CNR, Via Moruzzi 1, 56100 Pisa, Italy
Diabetes Care 29:2275-81. 2006..Thiazolidinediones (TZDs) improve peripheral insulin sensitivity, but the effect on the liver is less clear. The goal of this study was to examine the effect of TZDs on GNG...
Research Grants
- REGULATION OF HEPATIC AND PERIPHERAL GLUCOSE METABOLISMRalph A DeFronzo; Fiscal Year: 2010..We believe that these studies will yield new insights into the etiology of insulin resistance in T2DM and identify novel therapeutic approaches to reverse the defects in insulin action and restore normoglycemia. ..
- REGULATION OF HEPATIC & PERIPHERAL GLUCOSE METABOLISMRalph Defronzo; Fiscal Year: 1993..We also shall examine the effects of chronic hyperinsulinemia on the oxidative and non-oxidative pathways of glucose disposal...
- REGULATION OF HEPATIC AND PERIPHERAL GLUCOSE METABOLISMRalph Defronzo; Fiscal Year: 1999..Regardless, Mexican Americans comprise 5% of the US population (12 million people) and definition of the cause of NIDDM in this ethnic group alone would have major scientific, therapeutic, and health care delivery significance. ..
- REGULATION OF HEPATIC AND PERIPHERAL GLUCOSE METABOLISMRalph A DeFronzo; Fiscal Year: 2010..We believe that these studies will yield new insights into the etiology of insulin resistance in T2DM and identify novel therapeutic approaches to reverse the defects in insulin action and restore normoglycemia. ..
